Tuberculosis MDR-TB & XDR-TB The 2008 Report
A toolkit to equip young people with the skills to become powerful advocates for Youth Sexual Reproductive Health and Rights (YSRH&R)
Accessed: 17.11.2019
Advocacy, communication and social mobilization for TB control
Vision 2030
Accessed: 17.11.2019
Informe sobre poplaciones clave.
Key populations brief
Accessed 2017
СЕЛЬСКОЕ НАСЕЛЕНИЕ
ОСНОВНЫЕ ЗАТРОНУТЫЕ ГРУППЫ НАСЕЛЕНИЯ. КРАТКОЕ РУКОВОДСТВО.
Informe sobre poblaciones clave
Accessed November 2017
Key Populations Brief
Accessed November 2017
Advocacy report March 2011
303100 03/2011 E 1,000
TB policies in 24 Countries
A survey of prevention, testing and treatment policies and practices
Лечение туберкулеза в 24 странах
Исследование диагностической и клинической практики
Rapport sur les populations clés.
Rapport sur les populations clès
Accessed November 2017
Rapport de plaidoyer Mars 2011
303100 03/2011 E 1,000
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...depend on these medicines to treat bacterial infections, a continuous supply of new effective antibiotics is needed. The report identifies five key challenges that must be solved in order to achieve sustainable access for all, and charts out options for governmental action in response to each of them.
more
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.
more
Experience of national TB partnerships